XML 70 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Financing Arrangements - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 30, 2019
Dec. 31, 2018
Oct. 31, 2017
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Debt Instrument [Line Items]                
Equity option       $ 20,000,000.0        
Proceeds from related party debt financing         $ 245,000,000 $ 113,700,000 $ 0  
Loss on extinguishment of debt         $ 0 4,851,000 $ 0  
Common Shares                
Debt Instrument [Line Items]                
Warrants exercisable as a percentage of principal amount of loan       3.00%        
Warrants outstanding (in USD per share)         73,710      
Line of Credit | NovaQuest                
Debt Instrument [Line Items]                
Maximum borrowing commitment       $ 60,000,000.0        
Debt issued     $ 54,000,000.0 6,000,000.0        
Equity commitment related to note issuance       $ 20,000,000.0        
Interest rate       15.00%        
Quarterly interest rate       5.00%        
Deferred interest rate       10.00%        
Principal repayment of debt $ 60,000,000.0              
Accrued interest repayment of debt 7,600,000              
Prepayment penalty 2,400,000              
Term Loan | Hercules                
Debt Instrument [Line Items]                
Maximum borrowing commitment       $ 40,000,000.0        
Interest rate       8.25%        
Principal repayment of debt 40,000,000.0              
Accrued interest repayment of debt 300,000              
Prepayment penalty 400,000              
Principal amount funded       $ 25,000,000.0       $ 15,000,000.0
End-of-term charge $ 2,600,000              
Term Loan | Hercules | Prime Rate                
Debt Instrument [Line Items]                
Variable interest rate       4.00%        
Term Loan | Letter Agreement with Sumitomo Dainippon Pharma, Co., Ltd.                
Debt Instrument [Line Items]                
Proceeds from related party debt financing   $ 113,700,000            
Loss on extinguishment of debt           $ 4,900,000    
Tranche 1 | Common Shares                
Debt Instrument [Line Items]                
Number of securities exercisable by warrant (in shares)       49,800        
Exercise price of warrants (in USD per share)       $ 15.06        
Tranche 2 | Common Shares                
Debt Instrument [Line Items]                
Number of securities exercisable by warrant (in shares)       23,910        
Exercise price of warrants (in USD per share)       $ 18.82        
NovaQuest | Private Placement                
Debt Instrument [Line Items]                
Shares purchased by NovaQuest (in shares)       138,361        
Shares purchased by NovaQuest       $ 2,000,000.0        
NovaQuest | Private Placement, One                
Debt Instrument [Line Items]                
Shares purchased by NovaQuest (in shares)     1,082,977          
Shares purchased by NovaQuest     $ 18,000,000.0          
NovaQuest | Private Placement, Two                
Debt Instrument [Line Items]                
Shares purchased by NovaQuest (in shares)     1,203,307          
Shares purchased by NovaQuest     $ 20,000,000.0